معرفی
Dr. Robert J. Mayer is a Professor of Medicine at Harvard Medical School and holds dual leadership roles as Faculty Vice President for Academic Affairs at Dana-Farber Cancer Institute and Faculty Associate Dean for Admissions at Harvard Medical School. He specializes in gastrointestinal oncology, with a focus on multidisciplinary research in colorectal, pancreatic, and other gastrointestinal cancers. His clinical expertise includes advanced treatments like cetuximab and precision oncology approaches.
Dr. Mayer received his MD from Harvard Medical School (1969) and completed postgraduate training in internal medicine at Mount Sinai Hospital. He served as President of the American Society of Clinical Oncology (1997) and has led major clinical trials through the Cancer and Leukemia Group B (Alliance). His research emphasizes adjuvant therapies, biomarker development, and improving outcomes for metastatic cancers.
His awards include the ASCO Distinguished Achievement Award (2019), Ellen and Stephen Fine Teaching Award (2010), and George W. Thorn Clinical Education Award (1990). He has authored over 600 publications, focusing on topics like vitamin D’s role in colorectal cancer survival, physical activity’s impact on recurrence, and genomic characterization of pancreatic cancer.
Dr. Mayer’s leadership extends to medical education innovation, including curriculum design and admissions policy at Harvard Medical School. His clinical trials have defined standards for colon/rectal cancer adjuvant therapy and advanced pancreatic cancer management.
